Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Personalis, Inc. United States | 1 | 413 |
|
Tempus AI United States | 2 | 646 |
|
Foundation Medicine, Inc. United States | 2 | 405 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 118 |
|
MayoComplete Solid Tumor Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 476 |
|
The Jackson Laboratory for Genomic Medicine United States | 1 | 517 |
|
PathGroup United States | 73 | 505 |
|
OmniSeq, Inc. United States | 1 | 525 |
|
GTC-Solid Tumor Profile Plus Fusion/Expression (DNA and RNA) Genomic Testing Cooperative, LCA United States | 1 | 434 |
|
Genomic Testing Cooperative, LCA United States | 1 | 434 |
|
GTC-Hematology Profile Plus Fusion/Expression (DNA and RNA) Genomic Testing Cooperative, LCA United States | 1 | 254 |
|
Genomic Testing Cooperative, LCA United States | 1 | 247 |
|
NeoTYPE® Discovery Profile for Solid Tumors NeoGenomics Laboratories NeoGenomics Laboratories, Inc. United States | 1 | 315 |
|
Providence St. Joseph Health Molecular Genomics Laboratory Providence St Joseph Health United States | 1 | 523 |
|
Comprehensive Solid Tumor Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 2 | 315 |
|
Hyperparathyroidism (WES based NGS panel of 11 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 11 |
|
Multiple endocrine neoplasia susceptibility 1 (sequence analysis of CDKN2C gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
FISH analysis of CKS1B/CDKN2C genes amplification/deletion CGC Genetics Unilabs Portugal | 1 | 1 |
|
OnkoSight Advanced Comprehensive Solid Tumor Panel (DNA/RNA) BioReference Health United States | 1 | 523 |
|
OnkoSight Advanced 523 Gene NGS Panel BioReference Health United States | 1 | 523 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.